Go big or go home: NIH, Bill and Melin­da Gates Foun­da­tion join forces to make gene ther­a­pies af­ford­able

Gene ther­a­pies — ap­proved and in de­vel­op­ment — of­fer the po­ten­tial for cures. These an­ti­dotes don’t come cheap though, and the NIH and the Bill and Melin­da Gates Foun­da­tion are open­ing their cof­fers in a bid to de­vel­op “af­ford­able” ge­net­ic treat­ments for glob­al use.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER